Renata Zrinski Topić

Dr. Renata Zrinski Topić

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Biochemia Medica
Verified
Journal Article
Open access
RTRenata Zrinski Topić
Renata Zrinski Topić
SDSlavica Dodig
Slavica Dodig
Eosinophil catonic protein – current concepts and controversies

20 June 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
Tatjana Vilibic-CavlekTatjana Vilibic-Cavlek
Tatjana Vilibic-Cavlek
VSVladimir Stevanovic
Vladimir Stevanovic
MIMaja Ilic
Maja Ilic
LBLjubo Barbić
Ljubo Barbić
KCKrunoslav Capak
Krunoslav Capak
BKBernard Kaic
Bernard Kaic
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus with a pandemic spread. So far, a total of 349,910 SARS-CoV-2 cases and 7687 deaths were reported in Croatia. We analyzed the seroprevalence and neutralizing (NT) antibody response in the Croatian general population after the first (May–July 2020) and second (December 2020–February 2021) pandemic wave. Initial serological testing was performed using a commercial ELISA, with confirmation of reactive samples by a virus neutralization test (VNT). A significant difference in the overall seroprevalence rate was found after the first (ELISA 2.2%, VNT 0.2%) and second waves (ELISA 25.1%, VNT 18.7%). Seropositive individuals were detected in all age groups, with significant differences according to age. The lowest prevalence of NT antibodies was documented in the youngest (<10 years; 16.1%) and the oldest (60–69/70+ years; 16.0% and 12.8%, respectively) age groups. However, these age groups showed the highest median NT titers (32–64). In other groups, seropositivity varied from 19.3% to 21.5%. A significant weak positive correlation between binding antibody level as detected by ELISA and VNT titer (rho = 0.439, p < 0.001) was observed. SARS-CoV-2 NT antibody titers seem to be age-related, with the highest NT activity in children under 10 years and individuals above 50 years.

1 February 2011 in Archives of Medical Research
Verified
Journal Article
Closed access
RTRenata Zrinski Topić
Renata Zrinski Topić
IZIvka Zoričić-Letoja
Ivka Zoričić-Letoja
IPIvan Pavić
Ivan Pavić
SDSlavica Dodig
Slavica Dodig

1 February 2009 in Archives of Medical Research
Verified
Journal Article
Closed access
RTRenata Zrinski Topić
Renata Zrinski Topić
SDSlavica Dodig
Slavica Dodig
IZIvka Zoričić-Letoja
Ivka Zoričić-Letoja

13 January 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
RTRenata Zrinski Topić
Renata Zrinski Topić
JKJasna Lenicek Krleza
Jasna Lenicek Krleza
Currently, there are no validated guidelines or recommendations for how to interpret cardiac biomarkers in the pediatric population. The most commonly used cardiac biomarkers are cardiac troponins and natriuretic peptides, but the clinical value of common cardiac biomarkers in pediatric laboratory medicine is restricted due to age- and sex-specific interpretations, and there are no standardized cut-off values. The results from the studies on reference values, as well as results from clinical studies, are difficult to compare with identical studies due to the heterogeneity of subject characteristics (gestational and chronological age, sex, pubertal status, menstrual cycle, exercise), assay characteristics (type of assay, generation of assay, analytical platform used), and experimental protocol characteristics (prospective or retrospective studies, reference population selection, patient population selection, inclusion and exclusion criteria, number of subjects). Future studies need to establish evidence-based cut-offs for specific indications to optimize utilization and standardize the interpretation of common cardiac biomarkers in neonates, children, and adolescents. The aim of this article was to summarize the current analytical and clinical limitations of cardiac troponins and natriuretic peptides in the pediatric population, as informed by the existing published literature.

14 June 2020 in Biochemia Medica
Verified
Journal Article
Open access
PDF file
RTRenata Zrinski Topić
Renata Zrinski Topić
JKJasna Leniček Krleža
Jasna Leniček Krleža
Verification of the Canadian Laboratory Initiative on Paediatric Reference Intervals (CALIPER) reference values in Croatian children and adolescents